Genzyme and Medicines for Malaria Venture Announce new Collaboration with Advinus Therapeutics 26 August 2008 The collaboration is aimed to accelerate discovery of improved treatments for specific patient groups most at risk for malaria.
Dyax and AVEO Pharmaceuticals Announce Antibody Library License Agreement 26 August 2008 Dyax has granted AVEO a non-exclusive license to its proprietary antibody phage display libraries for the discovery and development of therapeutic antibodies.
Clinical-Scale Generation of Functional Red Blood Cells from Human Embryonic Stem Cells 20 August 2008 ACT reports that it is feasible to differentiate and mature hESCs into functional oxygen-carrying RBCs under conditions suitable for scale-up.
AstraZeneca Announces Partnership with Singapore Institutions to Develop Anti-Cancer Compounds 19 August 2008 The collaboration aims to further build AstraZeneca's drug development capabilities in Asia and speed up access to new medicines of potential benefit to patients.
SymBio Pharmaceuticals and Eisai Sign License Agreement for Bendamustine Hydrochloride 19 August 2008 The agreement aims at the co-development and commercialization of bendamustine hydrochloride in Japan, with exclusive rights retained by SymBio.
Eden Biodesign Signs Marketing Services Agreement with Human Genome Sciences 19 August 2008 Both companies will use their combined expertise to provide customers with transition into cGMP manufacturing at scales up to 20,000L.
University of Nevada Deploys Proteus by GenoLogics for their Data Management System 14 August 2008 The University has selected GenoLogics to install their informatics solution to aggregate data from several proteomic technological platforms.
AGOWA Genomics Adds the Roche Genome Sequencer FLX System to Its Sequencing Portfolio 13 August 2008 The acquisition of the Roche GS FLX will enable AGOWA genomics to meet the market demands for higher capacity and higher throughput.
ImmunoGen Announces sanofi-aventis Licenses Expanded Access to the Company's TAP Technology 13 August 2008 The option enables sanofi-aventis to evaluate the maytansinoid TAP technology to develop products to specific targets, with certain restrictions.
Cangen and Dai Nippon Printing Co. Move Forward with Development of an Early Stage Lung Cancer Diagnostic 13 August 2008 The collaboration has resulted in successful first phase testing that utilized an assay technology combining technologies from each party.